Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
Conditions
Ototoxicity | Unspecified Childhood Solid Tumor, Protocol Specific
What is the purpose of this trial?
RATIONALE: New ways to find out about hearing loss after treatment with chemotherapy may improve the ability to plan cancer treatment and may help patients live more comfortably.
PURPOSE: This clinical trial is assessing ear damage in young cancer patients treated with cisplatin.
Participation Guidelines
- Age:
- 1 Year - 18 Years
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- Children's Oncology Group
National Cancer Institute (NCI) - Dates:
- May 2007
- Last Updated:
- April 2, 2011
- Study HIC#:
- 1101007858
Clinicaltrials.gov ID: NCT00458887
For more information about this trial, contact:
Investigator
Nina Kadan-Lottick, MD
Principal Investigator
